The association between SPRY4 (Sprouty RTK Signaling Antagonist 4) and Testicular Germ Cell Tumor is a manually-curated gene–disease association, drawing on a single expert-curated source, which records a susceptibility locus.
Sources1
Clinical variants0
Symptoms14
Compounds0
Trials0
Publications2
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.